IGF2-AS (IGF2 antisense RNA) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: IGF2-AS (IGF2 antisense RNA) Homo sapiens
Analyze
Symbol: IGF2-AS
Name: IGF2 antisense RNA
RGD ID: 1344250
HGNC Page HGNC:14062
Description: Predicted to be located in cytoplasm.
Type: ncrna (Ensembl: lncRNA)
RefSeq Status: REVIEWED
Previously known as: IGF2-AS1; IGF2AS; MGC168198; PEG8
RGD Orthologs
Mouse
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38112,140,512 - 2,148,666 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl112,140,501 - 2,148,666 (+)EnsemblGRCh38hg38GRCh38
GRCh37112,161,742 - 2,169,896 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36112,118,313 - 2,126,470 (+)NCBINCBI36Build 36hg18NCBI36
Build 34112,118,322 - 2,126,470NCBI
Celera112,198,265 - 2,206,401 (+)NCBICelera
Cytogenetic Map11p15.5NCBI
HuRef111,952,022 - 1,960,158 (+)NCBIHuRef
CHM1_1112,160,711 - 2,168,849 (+)NCBICHM1_1
T2T-CHM13v2.0112,228,165 - 2,236,316 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component
cytoplasm  (ISO)

References

References - curated
# Reference Title Reference Citation
1. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
2. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:10731720   PMID:11181995   PMID:12477932   PMID:12603530   PMID:12702581   PMID:17289909   PMID:17554260   PMID:17632545   PMID:18676680   PMID:19170196   PMID:19625176   PMID:19692168  
PMID:19767753   PMID:19913121   PMID:19948975   PMID:20564319   PMID:20628086   PMID:20819778   PMID:21829393   PMID:23193016   PMID:24824313   PMID:31183590   PMID:31317640   PMID:31850718  
PMID:32513696   PMID:33175607   PMID:34101307   PMID:34109707   PMID:34474977   PMID:34516353   PMID:36508036  


Genomics

Comparative Map Data
IGF2-AS
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38112,140,512 - 2,148,666 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl112,140,501 - 2,148,666 (+)EnsemblGRCh38hg38GRCh38
GRCh37112,161,742 - 2,169,896 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36112,118,313 - 2,126,470 (+)NCBINCBI36Build 36hg18NCBI36
Build 34112,118,322 - 2,126,470NCBI
Celera112,198,265 - 2,206,401 (+)NCBICelera
Cytogenetic Map11p15.5NCBI
HuRef111,952,022 - 1,960,158 (+)NCBIHuRef
CHM1_1112,160,711 - 2,168,849 (+)NCBICHM1_1
T2T-CHM13v2.0112,228,165 - 2,236,316 (+)NCBIT2T-CHM13v2.0
Igf2os
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm397142,213,417 - 142,224,093 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl7142,213,430 - 142,224,093 (+)EnsemblGRCm39 Ensembl
GRCm387142,659,680 - 142,670,356 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl7142,659,693 - 142,670,356 (+)EnsemblGRCm38mm10GRCm38
MGSCv377149,845,598 - 149,856,261 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv367142,469,083 - 142,479,746 (+)NCBIMGSCv36mm8
Celera7142,416,023 - 142,426,685 (+)NCBICelera
Cytogenetic Map7F5NCBI
cM Map787.99NCBI

Variants

.
Variants in IGF2-AS
16 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 11p15.5-15.4(chr11:196966-3377077)x3 copy number gain See cases [RCV000050947] Chr11:196966..3377077 [GRCh38]
Chr11:196966..3398307 [GRCh37]
Chr11:186966..3354883 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:196966-4435344)x3 copy number gain See cases [RCV000050927] Chr11:196966..4435344 [GRCh38]
Chr11:196966..4456574 [GRCh37]
Chr11:186966..4413150 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:218365-3377077)x3 copy number gain See cases [RCV000053614] Chr11:218365..3377077 [GRCh38]
Chr11:218365..3398307 [GRCh37]
Chr11:208365..3354883 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:196966-3624139)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053592]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053592]|See cases [RCV000053592] Chr11:196966..3624139 [GRCh38]
Chr11:196966..3645369 [GRCh37]
Chr11:186966..3601945 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-13(chr11:202758-31726224)x3 copy number gain See cases [RCV000053613] Chr11:202758..31726224 [GRCh38]
Chr11:202758..31747772 [GRCh37]
Chr11:192758..31704348 [NCBI36]
Chr11:11p15.5-13
pathogenic
NM_001042376.2(INS-IGF2):c.*488G>A single nucleotide variant Malignant melanoma [RCV000069292] Chr11:2146304 [GRCh38]
Chr11:2167534 [GRCh37]
Chr11:2124110 [NCBI36]
Chr11:11p15.5
not provided
GRCh38/hg38 11p15.5-15.1(chr11:446754-18904742)x3 copy number gain See cases [RCV000133997] Chr11:446754..18904742 [GRCh38]
Chr11:446754..18926289 [GRCh37]
Chr11:436754..18882865 [NCBI36]
Chr11:11p15.5-15.1
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:1975511-2888695)x3 copy number gain See cases [RCV000136112] Chr11:1975511..2888695 [GRCh38]
Chr11:1996741..2909925 [GRCh37]
Chr11:1953317..2866501 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:1537379-3360769)x3 copy number gain See cases [RCV000136847] Chr11:1537379..3360769 [GRCh38]
Chr11:1558609..3381999 [GRCh37]
Chr11:1515185..3338575 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:1975511-3624139)x1 copy number loss See cases [RCV000137066] Chr11:1975511..3624139 [GRCh38]
Chr11:1996741..3645369 [GRCh37]
Chr11:1953317..3601945 [NCBI36]
Chr11:11p15.5-15.4
uncertain significance
GRCh38/hg38 11p15.5-15.4(chr11:61793-10727969)x3 copy number gain See cases [RCV000139987] Chr11:61793..10727969 [GRCh38]
Chr11:61793..10749516 [GRCh37]
Chr11:51793..10706092 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5(chr11:2127344-2159430)x3 copy number gain See cases [RCV000141243] Chr11:2127344..2159430 [GRCh38]
Chr11:2148574..2180660 [GRCh37]
Chr11:2105150..2137236 [NCBI36]
Chr11:11p15.5
uncertain significance
GRCh38/hg38 11p15.5-15.4(chr11:1132899-3213923)x1 copy number loss See cases [RCV000142464] Chr11:1132899..3213923 [GRCh38]
Chr11:1126807..3235153 [GRCh37]
Chr11:1116807..3191729 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5-15.4(chr11:196855-5321874)x3 copy number gain See cases [RCV000142890] Chr11:196855..5321874 [GRCh38]
Chr11:196855..5343104 [GRCh37]
Chr11:186855..5299680 [NCBI36]
Chr11:11p15.5-15.4
pathogenic
GRCh38/hg38 11p15.5(chr11:2106943-2565669)x3 copy number gain See cases [RCV000143587] Chr11:2106943..2565669 [GRCh38]
Chr11:2128173..2586899 [GRCh37]
Chr11:2084749..2543475 [NCBI36]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-15.4(chr11:193187-5291338)x3 copy number gain See cases [RCV000446036] Chr11:193187..5291338 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5-15.3(chr11:193146-12643136) copy number gain Silver-Russell syndrome 1 [RCV000767567] Chr11:193146..12643136 [GRCh37]
Chr11:11p15.5-15.3
pathogenic
GRCh37/hg19 11p15.5-15.4(chr11:230615-6644927)x3 copy number gain See cases [RCV000449417] Chr11:230615..6644927 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5-12(chr11:230615-37698540)x3 copy number gain See cases [RCV000511561] Chr11:230615..37698540 [GRCh37]
Chr11:11p15.5-12
pathogenic
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470) copy number gain See cases [RCV000511729] Chr11:230616..134938470 [GRCh37]
Chr11:11p15.5-q25
pathogenic
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)x3 copy number gain See cases [RCV000510881] Chr11:230616..134938470 [GRCh37]
Chr11:11p15.5-q25
pathogenic
GRCh37/hg19 11p15.5-14.3(chr11:230615-25584362)x3 copy number gain See cases [RCV000512225] Chr11:230615..25584362 [GRCh37]
Chr11:11p15.5-14.3
pathogenic
GRCh37/hg19 11p15.5-13(chr11:230615-31995219)x3 copy number gain See cases [RCV000512477] Chr11:230615..31995219 [GRCh37]
Chr11:11p15.5-13
pathogenic
GRCh37/hg19 11p15.5(chr11:1690968-2277648)x3 copy number gain See cases [RCV000512345] Chr11:1690968..2277648 [GRCh37]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-15.4(chr11:230615-9704511)x3 copy number gain not provided [RCV000683369] Chr11:230615..9704511 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5-15.1(chr11:230615-17099213)x3 copy number gain not provided [RCV000683372] Chr11:230615..17099213 [GRCh37]
Chr11:11p15.5-15.1
pathogenic
NM_001042376.3(INS-IGF2):c.581G>A (p.Arg194Gln) single nucleotide variant Inborn genetic diseases [RCV003183429] Chr11:2147634 [GRCh38]
Chr11:2168864 [GRCh37]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-q25(chr11:198510-134934063)x3 copy number gain not provided [RCV000737348] Chr11:198510..134934063 [GRCh37]
Chr11:11p15.5-q25
pathogenic
GRCh37/hg19 11p15.5-q25(chr11:70864-134938470)x3 copy number gain not provided [RCV000749874] Chr11:70864..134938470 [GRCh37]
Chr11:11p15.5-q25
pathogenic
NC_000011.9:g.(?_612625)_(2193840_?)dup duplication Immunodeficiency 39 [RCV001033372] Chr11:612625..2193840 [GRCh37]
Chr11:11p15.5
uncertain significance
NC_000011.9:g.(?_532616)_(2906985_?)dup duplication Neuronal ceroid lipofuscinosis [RCV001032557] Chr11:532616..2906985 [GRCh37]
Chr11:11p15.5-15.4
uncertain significance
GRCh37/hg19 11p15.5-13(chr11:235934-33826995)x3 copy number gain not provided [RCV001006372] Chr11:235934..33826995 [GRCh37]
Chr11:11p15.5-13
pathogenic
GRCh37/hg19 11p15.5(chr11:1436158-2321134)x3 copy number gain not provided [RCV001259591] Chr11:1436158..2321134 [GRCh37]
Chr11:11p15.5
pathogenic
GRCh37/hg19 11p15.5-15.4(chr11:230615-4851537)x3 copy number gain See cases [RCV001263059] Chr11:230615..4851537 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5-15.4(chr11:210300-8664358)x3 copy number gain Silver-Russell syndrome 1 [RCV001263222] Chr11:210300..8664358 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5(chr11:1621232-2228572) copy number gain Beckwith-Wiedemann syndrome [RCV002280763] Chr11:1621232..2228572 [GRCh37]
Chr11:11p15.5
pathogenic
NC_000011.9:g.(?_298501)_(4113028_?)dup duplication Early infantile epileptic encephalopathy with suppression bursts [RCV001316682] Chr11:298501..4113028 [GRCh37]
Chr11:11p15.5-15.4
uncertain significance
NC_000011.9:g.(?_612625)_(2193840_?)dup duplication Autosomal recessive DOPA responsive dystonia [RCV001301561]|Immunodeficiency 39 [RCV001033372] Chr11:612625..2193840 [GRCh37]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-15.4(chr11:10701-5080415)x2 copy number gain See cases [RCV001310286] Chr11:10701..5080415 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
NM_001007139.6(IGF2):c.-248-73= single nucleotide variant INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM [RCV000015870] Chr11:2147880 [GRCh38]
Chr11:2169110 [GRCh37]
Chr11:11p15.5
benign
GRCh37/hg19 11p15.5-15.4(chr11:230615-5525355)x3 copy number gain not provided [RCV001825269] Chr11:230615..5525355 [GRCh37]
Chr11:11p15.5-15.4
not provided
GRCh37/hg19 11p15.5(chr11:1719815-2321109)x3 copy number gain not provided [RCV001827983] Chr11:1719815..2321109 [GRCh37]
Chr11:11p15.5
likely pathogenic
NC_000011.9:g.(?_1278740)_(2906719_?)dup duplication Autosomal recessive DOPA responsive dystonia [RCV003113999] Chr11:1278740..2906719 [GRCh37]
Chr11:11p15.5-15.4
uncertain significance
NC_000011.9:g.(?_721044)_(3988932_?)dup duplication not provided [RCV003113442] Chr11:721044..3988932 [GRCh37]
Chr11:11p15.5-15.4
uncertain significance
GRCh37/hg19 11p15.5-14.2(chr11:230615-26881146)x3 copy number gain See cases [RCV002286351] Chr11:230615..26881146 [GRCh37]
Chr11:11p15.5-14.2
pathogenic
NC_000011.10:g.(499700_4999400)_(5279346_5279697)del deletion Thalassemia, gamma-delta-beta [RCV000015529] Chr11:4999400..5279346 [GRCh38]
Chr11:11p15.5-15.4
pathogenic
NM_001042376.3(INS-IGF2):c.584C>G (p.Pro195Arg) single nucleotide variant Inborn genetic diseases [RCV002902078] Chr11:2147631 [GRCh38]
Chr11:2168861 [GRCh37]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-15.4(chr11:230616-8250724)x3 copy number gain not provided [RCV002472435] Chr11:230616..8250724 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
NM_001042376.3(INS-IGF2):c.460C>G (p.Gln154Glu) single nucleotide variant Inborn genetic diseases [RCV002733781] Chr11:2147755 [GRCh38]
Chr11:2168985 [GRCh37]
Chr11:11p15.5
uncertain significance
NM_001042376.3(INS-IGF2):c.410G>A (p.Gly137Asp) single nucleotide variant Inborn genetic diseases [RCV002919305] Chr11:2147805 [GRCh38]
Chr11:2169035 [GRCh37]
Chr11:11p15.5
uncertain significance
NM_001042376.3(INS-IGF2):c.427G>A (p.Glu143Lys) single nucleotide variant Inborn genetic diseases [RCV003345216] Chr11:2147788 [GRCh38]
Chr11:2169018 [GRCh37]
Chr11:11p15.5
uncertain significance
GRCh37/hg19 11p15.5-15.4(chr11:192764-3362853)x3 copy number gain not provided [RCV003484828] Chr11:192764..3362853 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
GRCh37/hg19 11p15.5-15.4(chr11:230615-8821443)x3 copy number gain Russell-Silver syndrome [RCV003444025] Chr11:230615..8821443 [GRCh37]
Chr11:11p15.5-15.4
pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:737
Count of miRNA genes:384
Interacting mature miRNAs:413
Transcripts:ENST00000381361, ENST00000381363, ENST00000445504
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
IGF2  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,169,615 - 2,170,122UniSTSGRCh37
GRCh37112,152,567 - 2,153,356UniSTSGRCh37
Build 36112,126,191 - 2,126,698RGDNCBI36
Celera112,189,058 - 2,189,862UniSTS
Celera112,206,120 - 2,206,627RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,877 - 1,960,384UniSTS
HuRef111,943,089 - 1,943,889UniSTS
GeneMap99-GB4 RH Map1116.42UniSTS
NCBI RH Map1110.0UniSTS
ECD02194  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,169,406 - 2,170,244UniSTSGRCh37
Build 36112,125,982 - 2,126,820RGDNCBI36
Celera112,205,911 - 2,206,749RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,668 - 1,960,506UniSTS
ECD02763  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,166,711 - 2,167,529UniSTSGRCh37
Build 36112,123,287 - 2,124,105RGDNCBI36
Celera112,203,216 - 2,204,034RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,956,973 - 1,957,791UniSTS
ECD02954  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,163,166 - 2,163,977UniSTSGRCh37
Build 36112,119,742 - 2,120,553RGDNCBI36
Celera112,199,673 - 2,200,484RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,953,430 - 1,954,241UniSTS
ECD03070  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,164,000 - 2,164,807UniSTSGRCh37
Build 36112,120,576 - 2,121,383RGDNCBI36
Celera112,200,507 - 2,201,314RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,954,264 - 1,955,071UniSTS
ECD03071  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,165,812 - 2,166,619UniSTSGRCh37
Build 36112,122,388 - 2,123,195RGDNCBI36
Celera112,202,317 - 2,203,124RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,956,074 - 1,956,881UniSTS
ECD03179  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,164,942 - 2,165,745UniSTSGRCh37
Build 36112,121,518 - 2,122,321RGDNCBI36
Celera112,201,449 - 2,202,250RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,955,206 - 1,956,007UniSTS
ECD04781  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,167,680 - 2,168,434UniSTSGRCh37
Build 36112,124,256 - 2,125,010RGDNCBI36
Celera112,204,185 - 2,204,939RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,957,942 - 1,958,696UniSTS
ECD06903  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,160,901 - 2,161,597UniSTSGRCh37
Build 36112,117,477 - 2,118,173RGDNCBI36
Celera112,197,408 - 2,198,104RGD
Cytogenetic Map11p15.5UniSTS
ECD07090  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,168,620 - 2,169,311UniSTSGRCh37
Build 36112,125,196 - 2,125,887RGDNCBI36
Celera112,205,125 - 2,205,816RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,958,882 - 1,959,573UniSTS
ECD07757  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,162,353 - 2,163,026UniSTSGRCh37
Build 36112,118,929 - 2,119,602RGDNCBI36
Celera112,198,860 - 2,199,533RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,952,617 - 1,953,290UniSTS
ECD11676  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,161,623 - 2,162,188UniSTSGRCh37
Build 36112,118,199 - 2,118,764RGDNCBI36
Celera112,198,130 - 2,198,695RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,951,887 - 1,952,452UniSTS
REN117041  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,167,670 - 2,167,920UniSTSGRCh37
Build 36112,124,246 - 2,124,496RGDNCBI36
Celera112,204,175 - 2,204,425RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,957,932 - 1,958,182UniSTS
REN117042  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,167,899 - 2,168,156UniSTSGRCh37
Build 36112,124,475 - 2,124,732RGDNCBI36
Celera112,204,404 - 2,204,661RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,958,161 - 1,958,418UniSTS
REN117043  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,168,186 - 2,168,445UniSTSGRCh37
Build 36112,124,762 - 2,125,021RGDNCBI36
Celera112,204,691 - 2,204,950RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,958,448 - 1,958,707UniSTS
REN117044  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,168,422 - 2,168,674UniSTSGRCh37
Build 36112,124,998 - 2,125,250RGDNCBI36
Celera112,204,927 - 2,205,179RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,958,684 - 1,958,936UniSTS
REN117045  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,168,657 - 2,168,908UniSTSGRCh37
Build 36112,125,233 - 2,125,484RGDNCBI36
Celera112,205,162 - 2,205,413RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,958,919 - 1,959,170UniSTS
REN117046  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,168,891 - 2,169,117UniSTSGRCh37
Build 36112,125,467 - 2,125,693RGDNCBI36
Celera112,205,396 - 2,205,622RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,153 - 1,959,379UniSTS
REN117047  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,169,099 - 2,169,336UniSTSGRCh37
Build 36112,125,675 - 2,125,912RGDNCBI36
Celera112,205,604 - 2,205,841RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,361 - 1,959,598UniSTS
REN117048  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,169,316 - 2,169,541UniSTSGRCh37
Build 36112,125,892 - 2,126,117RGDNCBI36
Celera112,205,821 - 2,206,046RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,578 - 1,959,803UniSTS
REN117049  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,169,525 - 2,169,783UniSTSGRCh37
Build 36112,126,101 - 2,126,359RGDNCBI36
Celera112,206,030 - 2,206,288RGD
Cytogenetic Map11p15.5UniSTS
HuRef111,959,787 - 1,960,045UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 1 1 17 15 15 3 5 8 17 63 8 3 1
Low 227 208 654 314 75 308 1297 168 866 52 758 111 9 873 822 2
Below cutoff 1911 2103 896 216 561 68 2622 1936 2500 134 474 1111 152 331 1861 1

Sequence


RefSeq Acc Id: ENST00000381361
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,140,517 - 2,148,666 (+)Ensembl
RefSeq Acc Id: ENST00000381363
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,140,644 - 2,147,807 (+)Ensembl
RefSeq Acc Id: ENST00000445504
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,140,501 - 2,148,339 (+)Ensembl
RefSeq Acc Id: NR_028043
RefSeq Status: REVIEWED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,140,512 - 2,148,666 (+)NCBI
GRCh37112,161,758 - 2,169,896 (+)RGD
Celera112,198,265 - 2,206,401 (+)RGD
HuRef111,952,022 - 1,960,158 (+)ENTREZGENE
CHM1_1112,160,695 - 2,168,849 (+)NCBI
T2T-CHM13v2.0112,228,165 - 2,236,316 (+)NCBI
Sequence:
RefSeq Acc Id: NR_133657
RefSeq Status: REVIEWED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,140,512 - 2,148,666 (+)NCBI
CHM1_1112,160,695 - 2,168,849 (+)NCBI
T2T-CHM13v2.0112,228,165 - 2,236,316 (+)NCBI
Sequence:
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q6U949-F1-model_v2 AlphaFold Q6U949 1-168 view protein structure

Promoters
RGD ID:15096502
Promoter ID:EPDNEWNC_H1327
Type:initiation region
Name:IGF2-AS_1
Description:IGF2 antisense RNA [Source:HGNC Symbol;Acc:HGNC:14062]
SO ACC ID:SO:0000170
Source:EPDNEWNC (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,140,494 - 2,140,554EPDNEWNC

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:14062 AgrOrtholog
COSMIC IGF2-AS COSMIC
Ensembl Genes ENSG00000099869 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000381361 ENTREZGENE
  ENST00000445504 ENTREZGENE
GTEx ENSG00000099869 GTEx
HGNC ID HGNC:14062 ENTREZGENE
Human Proteome Map IGF2-AS Human Proteome Map
NCBI Gene 51214 ENTREZGENE
OMIM 610146 OMIM
PharmGKB PA29700 PharmGKB
RNAcentral URS0000A76E5D RNACentral
  URS0000A7761B RNACentral
UniProt IG2AS_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary A5PKV8 UniProtKB/Swiss-Prot
  A6NNQ2 UniProtKB/Swiss-Prot
  Q7Z712 UniProtKB/Swiss-Prot
  Q9P2W0 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2012-08-21 IGF2-AS  IGF2 antisense RNA  IGF2-AS  IGF2 antisense RNA (non-protein coding)  Symbol and/or name change 5135510 APPROVED
2012-04-24 IGF2-AS  IGF2 antisense RNA (non-protein coding)  IGF2-AS1  IGF2 antisense RNA 1 (non-protein coding)  Symbol and/or name change 5135510 APPROVED
2012-01-31 IGF2-AS1  IGF2 antisense RNA 1 (non-protein coding)  IGF2-AS  insulin-like growth factor 2 antisense (non-protein coding)  Symbol and/or name change 5135510 APPROVED
2011-09-27 IGF2-AS  insulin-like growth factor 2 antisense (non-protein coding)  IGF2AS  insulin-like growth factor 2 antisense (non-protein coding)  Symbol and/or name change 5135510 APPROVED
2011-09-13 IGF2AS  insulin-like growth factor 2 antisense (non-protein coding)  IGF2AS  insulin-like growth factor 2 antisense  Symbol and/or name change 5135510 APPROVED